Thrivent Financial for Lutherans Increases Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Thrivent Financial for Lutherans increased its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Rating) by 6.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,308 shares of the company’s stock after buying an additional 201 shares during the period. Thrivent Financial for Lutherans owned about 0.15% of iShares U.S. Pharmaceuticals ETF worth $616,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at about $25,000. First Manhattan Co. bought a new stake in iShares U.S. Pharmaceuticals ETF during the first quarter valued at about $46,000. Blair William & Co. IL bought a new stake in iShares U.S. Pharmaceuticals ETF during the first quarter valued at about $58,000. Y.D. More Investments Ltd bought a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at about $75,000. Finally, Concorde Asset Management LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at about $202,000.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of IHE stock opened at $174.69 on Thursday. iShares U.S. Pharmaceuticals ETF has a 1-year low of $166.99 and a 1-year high of $197.28. The stock’s 50-day moving average is $178.34 and its 200 day moving average is $181.63. The company has a market cap of $375.58 million, a P/E ratio of 16.27 and a beta of 0.70.

iShares U.S. Pharmaceuticals ETF Profile

(Get Rating)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.